ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -2 مورد

Respiratory syncytial virus (RSV) prevention: Choosing between maternal vaccination and newborn immunoprophylaxis

Respiratory syncytial virus (RSV) prevention: Choosing between maternal vaccination and newborn immunoprophylaxis
Use of palivizumab for infant immunoprophylaxis in selected patients is discussed in related UpToDate content.

IM: intramuscular; RSV: respiratory syncytial virus.

* In the northern hemisphere, vaccination should occur from September through January, so that newborns are protected during RSV season, which is from October through late March or early April. RSV season in the southern hemisphere is discussed in related UpToDate content.

¶ RSV vaccination is administered as a one-time dose; repeat vaccination in subsequent pregnancies is not recommended due to lack of data.

Δ In many settings, nirsevimab is in limited supply.

◊ In most cases, infants born to mothers vaccinated with RSVPreF during pregnancy will not be offered nirsevimab after birth. Exceptions include infants with a high-risk condition and/or that were delivered <14 days after maternal vaccination.
Graphic 143263 Version 2.0